Roger R Gomis

19PUBLICATIONS
93CO-AUTHORS
Molecular targetsBiomechanical engineeringPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 16, 2026
Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

|Aug 02, 2025
Economic impact of MAF testing for adjuvant bisphosphonate therapy in early breast cancer: a multi-regional budget impact analysis from a payer perspective.

João L Carapinha, Juan Carlos Tercero, Ralf van den Berg

|Jul 22, 2025
Correction: The PP2A regulator IER5L supports prostate cancer progression.

Jana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte

|Jul 18, 2024
The PP2A regulator IER5L supports prostate cancer progression.

Jana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte

|Nov 09, 2023
MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis.

Alicia Llorente, María Teresa Blasco, Irene Espuny

|Feb 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol

Pageof 4

Frequent Collaborators

4 joint publications

Arkaitz Carracedo

3 joint publications

Saioa Garcia-Longarte

2 joint publications

Cristina Figueras-Puig

2 joint publications

Antonio Berenguer-Llergo